Cancer treatment strategies targeting sphingolipid metabolism.
about
Recombinant human acid sphingomyelinase as an adjuvant to sorafenib treatment of experimental liver cancerThe pleiotropic roles of sphingolipid signaling in autophagyQuantitative proteomics reveals that Hsp90 inhibition preferentially targets kinases and the DNA damage response.Inhibition of sphingosine kinase 2 downregulates the expression of c-Myc and Mcl-1 and induces apoptosis in multiple myeloma.p53-independent early and late apoptosis is mediated by ceramide after exposure of tumor cells to photon or carbon ion irradiation.Sphingosine kinase 1 serves as a pro-viral factor by regulating viral RNA synthesis and nuclear export of viral ribonucleoprotein complex upon influenza virus infection.Lung cancer and lung injury: the dual role of ceramideSphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics.Role of IGF-1 receptor in radiation response.Potential Link between the Sphingosine-1-Phosphate (S1P) System and Defective Alveolar Macrophage Phagocytic Function in Chronic Obstructive Pulmonary Disease (COPD).Cardiomyocyte specific deficiency of serine palmitoyltransferase subunit 2 reduces ceramide but leads to cardiac dysfunction.Whole Reproductive System Non-Negative Matrix Factorization Mass Spectrometry Imaging of an Early-Stage Ovarian Cancer Mouse ModelCeramide--antiestrogen nanoliposomal combinations--novel impact of hormonal therapy in hormone-insensitive breast cancer.Synergistic Effect between Sphingosine-1-Phosphate and Chemotherapy Drugs against Human Brain-metastasized Breast Cancer MDA-MB-361 cells.Serum sphingolipidomic analyses reveal an upregulation of C16-ceramide and sphingosine-1-phosphate in hepatocellular carcinoma.Localized Irradiation of Cell Membrane by Auger Electrons Is Cytotoxic Through Oxidative Stress-Mediated Nontargeted EffectsSphingosine kinases are not required for inflammatory responses in macrophagesGenome-wide methylation analysis and epigenetic unmasking identify tumor suppressor genes in hepatocellular carcinoma.Lipid signalling in pathogenic fungi.PLP-dependent enzymes as entry and exit gates of sphingolipid metabolism.Sphingolipid metabolic pathway: an overview of major roles played in human diseases.Influenza viral manipulation of sphingolipid metabolism and signaling to modulate host defense system.Identification and functional analysis of the risk microRNAs associated with cerebral low-grade glioma prognosis.Sphingolipids in mitochondria.Induction of apoptosis in prostate cancer cells by the novel ceramidase inhibitor ceranib-2.Therapeutic Strategies and Pharmacological Tools Influencing S1P Signaling and Metabolism.Mechanisms of ceramide-induced COX-2-dependent apoptosis in human ovarian cancer OVCAR-3 cells partially overlapped with resveratrol.Glucosylceramide synthase protects glioblastoma cells against autophagic and apoptotic death induced by temozolomide and Paclitaxel.The transporter Spns2 is required for secretion of lymph but not plasma sphingosine-1-phosphate.Distinct plasma lipids profiles of recurrent ovarian cancer by liquid chromatography-mass spectrometry.Unexpected profile of sphingolipid contents in blood and bone marrow plasma collected from patients diagnosed with acute myeloid leukemia.Plasma lipid profiling and diagnostic biomarkers for oral squamous cell carcinoma.Tracking hippo in the cancer jungle.Combination of Mitochondrial and Plasma Membrane Citrate Transporter Inhibitors Inhibits De Novo Lipogenesis Pathway and Triggers Apoptosis in Hepatocellular Carcinoma Cells.Metabolomic study of corticosterone-induced cytotoxicity in PC12 cells by ultra performance liquid chromatography-quadrupole/time-of-flight mass spectrometry.Hair Cell Loss Induced by Sphingosine and a Sphingosine Kinase Inhibitor in the Rat Cochlea.Sphingosine but not sphingosine-1-phosphate stimulates suicidal erythrocyte death.MicroRNA meta-signature of oral cancer: evidence from a meta-analysis.
P2860
Q28533335-9E0154E2-1E53-4389-93B4-B35451F8ABA0Q33720239-573C20C5-CA05-4A64-A93D-D093C00AC822Q34100283-495FDB02-9001-4317-8389-DCA9624889A6Q34209320-D266DCB8-9DBA-43C8-A32A-AB8E1247F1C8Q34636385-B6BB5106-B7F9-48CE-9726-68D7BA2FC56AQ35020246-81FE5C97-E0E9-4325-A323-FDC7F3A223CAQ35207787-A7F93D41-C2D1-483E-8674-A2E5E4EAD141Q35324757-349BA553-651C-4EAB-AE24-F1BE7B094110Q35762239-3E051EFC-4B6A-4A1E-858F-F94C0B95E62CQ35814901-46AA99A5-683C-4726-BA4A-603D402884EAQ36002934-E3389B82-CE1B-4AED-B5A6-5141C36D01B5Q36012373-4D8CF65D-9BDB-4657-B04C-64C63B94A626Q36392653-6BC2C1B6-EA8E-4CDC-A996-6289281F6F99Q36746835-34755561-9B70-490D-8742-DB1269509FF0Q37109693-A6902B98-4D30-4C34-A3CD-BA20E1DFF680Q37267538-9D613C1E-BB85-4506-AA65-D4114C0F7734Q37289270-2EE9EA92-11FB-48C3-A266-DE91F395ECA5Q37481324-51BBFAAD-4155-4629-BD58-D9982A927139Q37482149-888D54CC-2BA2-4EF6-B6C4-4D5F2EFDA5A9Q37895205-CC247A62-C15F-46E0-BE43-FB1439D2BD34Q38132175-9E4AB6AE-4737-4755-8118-294E8BB89A9EQ38199691-051789D6-4D25-4601-856A-79A0DEEC98EAQ38432744-67A00AAA-B0CD-43DE-B9B7-A8F613D4BBCBQ38809404-41A6B3EF-4D8B-40E7-942F-5729A420D4A2Q38853452-D84B7D7B-7159-408E-BA8E-DAD6393F2ED9Q38915115-15258C1C-8C8D-41FA-A706-11698A9F4B56Q39180876-A05E8BCD-BF68-4CB8-8CA5-0DB0B958DBEFQ39413826-86175170-BDEE-4D31-96F0-C58B75D6F3CFQ39589659-A78524BA-E346-4538-8012-C6BD15CF81B5Q40606450-12840556-1814-4696-B4C2-A9EFEF0A13BCQ47094102-E683EB12-015A-4E5C-AFE2-5B483FBFF0FCQ47148343-99F7DC49-AF8B-40F6-8C2D-C14EAF74712EQ50612998-618AC8E9-9D87-47D8-97A0-A047F5DE1F9FQ52726195-489E965B-A396-47AD-8198-F46598D050A0Q53209811-9AF92C67-9A68-4D80-80C5-0B6C4B1F9B3AQ53309734-86362F81-60BE-40A8-8BE8-7A517585A68EQ54565672-47760810-12D6-4B41-BFF3-F53ED1E01A26Q55365878-A799E9F3-908F-4A49-81B3-C97996E56048
P2860
Cancer treatment strategies targeting sphingolipid metabolism.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Cancer treatment strategies targeting sphingolipid metabolism.
@ast
Cancer treatment strategies targeting sphingolipid metabolism.
@en
Cancer treatment strategies targeting sphingolipid metabolism.
@nl
type
label
Cancer treatment strategies targeting sphingolipid metabolism.
@ast
Cancer treatment strategies targeting sphingolipid metabolism.
@en
Cancer treatment strategies targeting sphingolipid metabolism.
@nl
prefLabel
Cancer treatment strategies targeting sphingolipid metabolism.
@ast
Cancer treatment strategies targeting sphingolipid metabolism.
@en
Cancer treatment strategies targeting sphingolipid metabolism.
@nl
P2860
P1476
Cancer treatment strategies targeting sphingolipid metabolism.
@en
P2093
Babak Oskouian
Julie D Saba
P2860
P304
P356
10.1007/978-1-4419-6741-1_13
P407
P577
2010-01-01T00:00:00Z